The year 2025 marked a strong leap forward for Vietnamese medicine, as a series of complex techniques were successfully ...
He] checked a box on his license to become an organ donor, and I'm alive today because of that,” one organ recipient said ...
Only the cutting of US support sparked by America’s growing revulsion at the Israel-linked Epstein class will end Israel’s ...
Twelve months after suffering a devastating ACL injury, halfback April Tomlinson is back, fit, firing, and helping keep the Dolphins’ Harvey 19s finals hopes alive.
Shares end lower; Electro Optic Systems’ Middle East deal; Dalrymple Bay raises $350m; BHP’s fresh Chinese blow; Immutep ...
MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...
For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk ...
"She was 17, and she died in the ER a few hours after my shift. It's been five years, and when I think about it, I start ...
Achieved YUTREPIA® net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarterMore than 3,600 unique prescriptions received and 2,900 patients treated to date ...
In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified ...
AND just like that, we have reached the final day of the 2026 Cheltenham Festival. After three days of thrills and spills, we have seven races to go before the countdown to the next Cheltenham ...
Zacks.com on MSN
PFE vs BMY: Which Large Oncology Drugmaker Is a Better Pick Now?
Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space. Oncology or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results